Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 7/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 4/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3832758 | 0.85 | UTS2R (0.49) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2478630 | 0.85 | HDAC1 (0.56) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2474066 | 0.84 | HDAC1 (0.62) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2470960 | 0.84 | UTS2R (0.46) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL3831092 | 0.83 | UTS2R (0.48) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL3837712 | 0.83 | UTS2R (0.48) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2472961 | 0.83 | HDAC1 (0.55) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2474421 | 0.83 | HDAC1 (0.48) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2476829 | 0.83 | UTS2R (0.49) | UTS2RHDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL2474402 | 0.83 | UTS2R (0.47) | UTS2RHDAC1HDAC3HDAC2NCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2107052-B1 | NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE | SANTEN PHARMACEUTICAL CO LTD (JP) | 2011-10-12 | — | — | EP | claimed |